Auna S.A. (NYSE:AUNA) Given Consensus Rating of “Hold” by Analysts

Auna S.A. (NYSE:AUNA) has been given an average rating of “Hold” by the five research firms that are presently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, two have given a hold recommendation, one has given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $6.9667.

Several brokerages have issued reports on AUNA. Wall Street Zen cut shares of Auna from a “strong-buy” rating to a “buy” rating in a report on Sunday, July 5th. Weiss Ratings reiterated a “sell (d)” rating on shares of Auna in a research note on Wednesday, June 24th. Finally, JPMorgan Chase & Co. cut their price target on shares of Auna from $6.00 to $5.00 and set a “neutral” rating on the stock in a report on Tuesday, May 26th.

Insider Buying and Selling

In other Auna news, President Leon Jesus Zamora acquired 30,000 shares of the stock in a transaction that occurred on Tuesday, May 26th. The shares were acquired at an average cost of $4.39 per share, with a total value of $131,700.00. Following the transaction, the president owned 45,914 shares of the company’s stock, valued at $201,562.46. The trade was a 188.51% increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director John Wilton sold 17,574 shares of the stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $4.17, for a total value of $73,283.58. Following the sale, the director owned 49,974 shares in the company, valued at approximately $208,391.58. This represents a 26.02% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders purchased 83,454 shares of company stock valued at $357,063.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the business. World Investment Advisors bought a new stake in Auna in the 4th quarter worth about $52,000. Clear Harbor Asset Management LLC purchased a new position in Auna in the 4th quarter worth about $63,000. Sanctuary Advisors LLC bought a new position in Auna during the 1st quarter valued at about $71,000. Virtu Financial LLC bought a new position in Auna during the 3rd quarter valued at about $75,000. Finally, Sage Investment Counsel LLC boosted its holdings in shares of Auna by 60.0% during the 4th quarter. Sage Investment Counsel LLC now owns 16,000 shares of the company’s stock valued at $79,000 after acquiring an additional 6,000 shares during the last quarter.

Auna Price Performance

AUNA opened at $5.08 on Monday. The stock has a 50-day moving average price of $4.95 and a 200-day moving average price of $5.09. The company has a debt-to-equity ratio of 1.76, a current ratio of 1.09 and a quick ratio of 1.00. The firm has a market cap of $375.69 million, a PE ratio of 19.52 and a beta of 0.62. Auna has a 1 year low of $4.09 and a 1 year high of $6.85.

Auna (NYSE:AUNA) last announced its quarterly earnings results on Friday, May 15th. The company reported $0.05 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.19 by ($0.14). Auna had a return on equity of 16.25% and a net margin of 1.53%.The firm had revenue of $336.84 million during the quarter, compared to the consensus estimate of $320.54 million. Sell-side analysts predict that Auna will post 0.81 earnings per share for the current fiscal year.

About Auna

Auna, listed on the New York Stock Exchange under the ticker symbol AUNA, is a Peruvian integrated healthcare services company headquartered in Lima. The firm operates a diversified care network that spans hospitals, outpatient medical centers, diagnostic imaging and laboratory facilities, as well as optical and dental clinics. Auna’s organizational structure is designed to support a continuum of care model, offering both general and specialized treatments across multiple touchpoints.

The company delivers a broad range of clinical services, including emergency care, inpatient and outpatient surgery, obstetrics, cardiology, oncology, orthopedics, and other specialized disciplines.